The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement ...

The individuals behind Purdue Pharma’s involvement in the U.S. opioid crisis reached a $7-billion settlement in January 2025.

The latest settlement is meant to address a drug addiction crisis that has led to over 700,000 opioid overdose deaths in the US over the past two decades.

The Office of the Attorney General came to a $7.4 billion settlement with the Sackler family and their company, Purdue Pharma ...

In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the ...

The proposed settlement calls on the Sacklers to pay $1.5 billion in the first three years, followed by $500 million after ...

Colorado is set to receive around $81 million from a $7.4 billion preliminary settlement with Purdue Pharma, the company’s ...

the new deal will not include a provision that protects the Sackler family from civil litigation – a point of contention that the Supreme Court said violated bankruptcy law. However, they will ...

Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.

Pennsylvania may receive up to $212 million over 15 years as part of a multi-state lawsuit settlement with Purdue Pharma and ...

Bankrupt Purdue Pharma LP and members of the billionaire Sackler family agreed to pay $7.4 billion to a group of US states, ...

If approved, the new plan would end the costliest corporate bankruptcy resulting from the U.S. opioid crisis. Purdue, under the leadership of the Sackler families, invented, manufactured and ...